Immix Biopharma

Price & Volume

Stats

Open	$8.29
Previous Close	$8.17
Day Range	$8.29-$8.88
52W Range	$1.34-$8.45
Market Cap	$423.6M
Shares Short	2M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$0.77

News

Yahoo Finance • 3 months ago

Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Yahoo Finance • 3 months ago

Immix Soars On NXC-201 Data In Relapsed/Refractory AL Amyloidosis; BLA Planned For 2026

Yahoo Finance • 3 months ago

Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Yahoo Finance • 3 months ago

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

About

CEO	Dr. Ilya Rachman M.B.A., M.D., Ph.D.
CFO	Mr. Gabriel Morris B.A.
Address	11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	18